Draft:Epicutis

American skin care brand From Wikipedia, the free encyclopedia


Epicutis is an American skincare brand, established in 2021, that is the consumer-facing division of Signum Biosciences, a biopharmaceutical company based in Princeton, New Jersey. The brand develops skincare products using biotechnology based on research into lipid signaling and neuroinflammation conducted by Signum Biosciences.[1][2][3]

  • Comment: Contains references with "source=chatgpt.com" in the URL. I have made no judgement on the rest of the draft content, but since ChatGPT has been used in the creation of this draft you must read WP:LLM and carefully review all the content of the draft to check for hallucinations, unsubstantiated text, non-existent references.
    If you are sure that no ChatGPT artefacts remain, you can re-submit this draft for review. qcne (talk) 20:52, 28 August 2025 (UTC)

History

Epicutis was founded in 2021 based on the research of molecular biologist Dr. Jeffry B. Stock at Princeton University, whose work contributed to the development of the brand’s product formulations.[1] The brand's initial product line, launched in 2021, featured ingredients including TSC and HYVIA.[1] In 2022, Epicutis introduced the Arctigenin Brightening Treatment (ABT).[4]

Products

The company markets a range of products, including a serum and a crème, that feature ingredients such as TSC, HYVIA, and Arctigenin.[4][1]

Epicutis's products are developed using compounds patented by its parent company, Signum Biosciences.[1] A notable ingredient, HYVIA, is a patented compound derived from chia seed oil. According to clinical studies, HYVIA has been shown to support skin hydration.[1][5][6]

References

Related Articles

Wikiwand AI